Literature DB >> 25047845

Distinct susceptibilities of corneal Pseudomonas aeruginosa clinical isolates to neutrophil extracellular trap-mediated immunity.

Qiang Shan1, Markryan Dwyer1, Samir Rahman1, Mihaela Gadjeva2.   

Abstract

Ocular bacterial keratitis, often associated with Pseudomonas aeruginosa bacterial infection, commonly occurs in contact lens wearers and may lead to vision impairment. In this study, we analyzed the contribution of neutrophil extracellular traps (NETs) to the mediation of protection during ocular keratitis. Both invasive and cytotoxic P. aeruginosa clinical isolates induced NET release by neutrophils. NETs carried the characteristic histone proteins, elastase, lysozyme, myeloperoxidase, and metabolic enzymes. While the invasive P. aeruginosa strains PAO1 (serogroup O5) and 6294 (serogroup O6) were trapped by NETs, the cytotoxic P. aeruginosa strains 6077, 6206 (serogroup O11), and PA14 (serogroup 010) were less sensitive to NET capture. The mechanism of escape by the cytotoxic strains from adhesion to NETs involved the shedding of outer membrane vesicles (OMVs) that outcompeted the cytotoxic P. aeruginosa strains for NET binding. When ocular infection was caused by an invasive strain in vivo, NETs were released at the ocular surface to capture bacteria, limiting their spread. Treatment with MNase I had a dose-dependent effect, with low doses of MNase speeding up bacterial clearance and high doses of MNase having toxic consequences. Cumulatively, our data suggest that NET-mediated immunity is a two-step process. Initially, pathogens attach to NET fragments; subsequently, upon nuclease activity, active serine proteases, which proteolytically degrade NET-associated proteins and promote DNase activity, are released. Therefore, a balance between NET production and NET degradation is needed to achieve maximal NET immunity.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25047845      PMCID: PMC4187885          DOI: 10.1128/IAI.02169-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Genotypic analysis of UK keratitis-associated Pseudomonas aeruginosa suggests adaptation to environmental water as a key component in the development of eye infections.

Authors:  Jayendra Shankar; Henri Sueke; Lutz Wiehlmann; Malcolm J Horsburgh; Stephen Tuft; Timothy J Neal; Stephen B Kaye; Craig Winstanley
Journal:  FEMS Microbiol Lett       Date:  2012-07-03       Impact factor: 2.742

2.  Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.

Authors:  Durga S Borkar; Suzanne M J Fleiszig; Chelsia Leong; Prajna Lalitha; Muthiah Srinivasan; Avanti A Ghanekar; Connie Tam; Wing Y Li; Michael E Zegans; Stephen D McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  JAMA Ophthalmol       Date:  2013-02       Impact factor: 7.389

3.  Stress-induced outer membrane vesicle production by Pseudomonas aeruginosa.

Authors:  Ian A Macdonald; Meta J Kuehn
Journal:  J Bacteriol       Date:  2013-04-26       Impact factor: 3.490

4.  NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis.

Authors:  Ritika Khandpur; Carmelo Carmona-Rivera; Anuradha Vivekanandan-Giri; Alison Gizinski; Srilakshmi Yalavarthi; Jason S Knight; Sean Friday; Sam Li; Rajiv M Patel; Venkataraman Subramanian; Paul Thompson; Pojen Chen; David A Fox; Subramaniam Pennathur; Mariana J Kaplan
Journal:  Sci Transl Med       Date:  2013-03-27       Impact factor: 17.956

5.  Impact of actin on adhesion and translocation of Enterococcus faecalis.

Authors:  Zhen Peng; Viktoria Krey; Hua Wei; Qianglai Tan; Roger Vogelmann; Matthias A Ehrmann; Rudi F Vogel
Journal:  Arch Microbiol       Date:  2013-12-21       Impact factor: 2.552

6.  Role of Pseudomonas aeruginosa peptidoglycan-associated outer membrane proteins in vesicle formation.

Authors:  Aimee K Wessel; Jean Liew; Taejoon Kwon; Edward M Marcotte; Marvin Whiteley
Journal:  J Bacteriol       Date:  2012-11-02       Impact factor: 3.490

7.  A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers.

Authors:  Kerstin Westritschnig; Romana Hochreiter; Gerhard Wallner; Christa Firbas; Michael Schwameis; Bernd Jilma
Journal:  Hum Vaccin Immunother       Date:  2013-09-24       Impact factor: 3.452

8.  In vitro resistance mechanisms of Neisseria meningitidis against neutrophil extracellular traps.

Authors:  Martin Lappann; Sophia Danhof; Frank Guenther; Silvana Olivares-Florez; Ines Louise Mordhorst; Ulrich Vogel
Journal:  Mol Microbiol       Date:  2013-06-25       Impact factor: 3.501

9.  Identification of novel bacterial plasminogen-binding proteins in the human pathogen Mycobacterium tuberculosis.

Authors:  Wendy Xolalpa; Antonio J Vallecillo; Martha Lara; Guillermo Mendoza-Hernandez; Marcelo Comini; Ralf Spallek; Mahavir Singh; Clara Espitia
Journal:  Proteomics       Date:  2007-09       Impact factor: 3.984

10.  Global substrate profiling of proteases in human neutrophil extracellular traps reveals consensus motif predominantly contributed by elastase.

Authors:  Anthony J O'Donoghue; Ye Jin; Giselle M Knudsen; Natascha C Perera; Dieter E Jenne; John E Murphy; Charles S Craik; Terry W Hermiston
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

View more
  21 in total

1.  TSP-1 Deficiency Alters Ocular Microbiota: Implications for Sjögren's Syndrome Pathogenesis.

Authors:  Marielle Terzulli; Laura Contreras-Ruiz; Laura Contreras Ruiz; Abirami Kugadas; Sharmila Masli; Mihaela Gadjeva
Journal:  J Ocul Pharmacol Ther       Date:  2015-05-26       Impact factor: 2.671

2.  Label-Free Quantitative Proteomics Distinguishes General and Site-Specific Host Responses to Pseudomonas aeruginosa Infection at the Ocular Surface.

Authors:  Jason Yeung; Mihaela Gadjeva; Jennifer Geddes-McAlister
Journal:  Proteomics       Date:  2020-01-07       Impact factor: 3.984

3.  Pathogenesis Mediated by Bacterial Membrane Vesicles.

Authors:  William J Gilmore; Natalie J Bitto; Maria Kaparakis-Liaskos
Journal:  Subcell Biochem       Date:  2021

4.  The cif Virulence Factor Gene Is Present in Isolates From Patients With Pseudomonas aeruginosa Keratitis.

Authors:  Christopher D Bahl; Jessica D St Laurent; R Siva Ganesa Karthikeyan; J Lakshmi Priya; Lalitha Prajna; Michael E Zegans; Dean R Madden
Journal:  Cornea       Date:  2017-03       Impact factor: 2.651

5.  Condensins are essential for Pseudomonas aeruginosa corneal virulence through their control of lifestyle and virulence programs.

Authors:  Hang Zhao; April L Clevenger; Phillip S Coburn; Michelle C Callegan; Valentin V Rybenkov
Journal:  Mol Microbiol       Date:  2022-02-09       Impact factor: 3.979

Review 6.  Cancer and inflammation.

Authors:  Lance L Munn
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-12-12

7.  Secreted Phosphatase and Deoxyribonuclease Are Required by Pseudomonas aeruginosa To Defend against Neutrophil Extracellular Traps.

Authors:  Mike Wilton; Tyler W R Halverson; Laetitia Charron-Mazenod; Michael D Parkins; Shawn Lewenza
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

8.  Neutrophil Extracellular Traps: New Aspects.

Authors:  N V Vorobjeva
Journal:  Moscow Univ Biol Sci Bull       Date:  2021-02-08

9.  Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction.

Authors:  Veronica Marcos; Zhe Zhou-Suckow; Ali Önder Yildirim; Alexander Bohla; Andreas Hector; Ljubomir Vitkov; Wolf Dietrich Krautgartner; Walter Stoiber; Matthias Griese; Oliver Eickelberg; Marcus A Mall; Dominik Hartl
Journal:  Mediators Inflamm       Date:  2015-03-31       Impact factor: 4.711

10.  Pseudomonas aeruginosa Outer Membrane Vesicles Triggered by Human Mucosal Fluid and Lysozyme Can Prime Host Tissue Surfaces for Bacterial Adhesion.

Authors:  Matteo M E Metruccio; David J Evans; Manal M Gabriel; Jagath L Kadurugamuwa; Suzanne M J Fleiszig
Journal:  Front Microbiol       Date:  2016-06-03       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.